Prospective Open-Label Phase II Trial of Individualized Anti-Thymocyte Globulin for Improved T-Cell Reconstitution after Pediatric Allogeneic Hematopoietic Cell Transplantation: The Parachute-Study

Rick Admiraal, Jaap Jan Boelens, Robbert G. M. Bredius et al.|Transplantation and Cellular Therapy|2020

Cited by 10